J. Miklosz

发表

Monitoring of Anticoagulant Activity of Dabigatran and Rivaroxaban in the Presence of Heparins

D. Pawlak, S. Yusa, K. Szczubiałka, 2022, Journal of clinical medicine.

Preclinical Toxicity and Safety of MM-129—First-in-Class BTK/PD-L1 Inhibitor as a Potential Candidate against Colon Cancer

D. Pawlak, M. Mojzych, K. Pawlak, 2021, Pharmaceutics.

The Inhibitory Effect of Protamine on Platelets is Attenuated by Heparin without Inducing Thrombocytopenia in Rodents

M. Nowakowska, D. Pawlak, M. Rusak, 2019, Marine drugs.

Heparin-Binding Copolymer as a Complete Antidote for Low-Molecular-Weight Heparins in Rats

M. Nowakowska, D. Pawlak, S. Yusa, 2020, The Journal of Pharmacology and Experimental Therapeutics.

Reversal Activity and Toxicity of Heparin-Binding Copolymer after Subcutaneous Administration of Enoxaparin in Mice

D. Pawlak, S. Yusa, K. Szczubiałka, 2021, International journal of molecular sciences.

Cardiovascular and Respiratory Toxicity of Protamine Sulfate in Zebrafish and Rodent Models

D. Pawlak, P. Podlasz, B. Kalaska, 2021, Pharmaceutics.

The effect of ChAdOx1 nCov-19 vaccine on arterial thrombosis development and platelet aggregation in female rats

D. Pawlak, Aleksandra Jakimczuk, B. Kalaska, 2022, Vaccine.

The neutralization of heparan sulfate by heparin-binding copolymer as a potential therapeutic target

B. Musielak, M. Nowakowska, D. Pawlak, 2019, RSC advances.

The toxicology of heparin reversal with protamine: past, present and future

B. Kalaska, J. Miklosz, A. Mogielnicki, 2016, Expert opinion on drug metabolism & toxicology.

Angiopoietin-Like 4 (ANGPTL4) in Patients with Psoriasis, Lichen Planus and Vitiligo—A Pilot Study from the Bialystok+ Polish Longitudinal University Study

K. Kamiński, D. Pawlak, I. Flisiak, 2022, Metabolites.

Monitoring of Cardiorespiratory Parameters in Rats—Validation Based on Pharmacological Stimulation

D. Pawlak, B. Kalaska, J. Miklosz, 2021, Pharmaceuticals.

The methods for removal of direct oral anticoagulants and heparins to improve the monitoring of hemostasis: a narrative literature review

B. Kalaska, J. Miklosz, A. Mogielnicki, 2023, Thrombosis Journal.

Anticoagulant Properties of Poly(sodium 2-(acrylamido)-2-methylpropanesulfonate)-Based Di- and Triblock Polymers.

M. Nowakowska, D. Pawlak, S. Yusa, 2018, Biomacromolecules.

Heparin-binding copolymer reverses effects of unfractionated heparin, enoxaparin, and fondaparinux in rats and mice.

I. Kasacka, M. Nowakowska, D. Pawlak, 2016, Translational research : the journal of laboratory and clinical medicine.

P372Heparin binding copolymer reverses the anticoagulant activity of low molecular weight heparins: safety and efficacy data in rats

M. Nowakowska, D. Pawlak, K. Szczubiałka, 2018 .

Anionic and cationic block copolymers as promising modulators of blood coagulation

B. Kalaska, J. Miklosz, A. Mogielnicki, 2023, European Polymer Journal.